Here is the latest shareholding Pattern of IND. SWIFT. For more details, see the IND. SWIFT financial fact sheet and IND. SWIFT share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 55.58 | 55.58 | 55.58 | 55.58 | 55.58 | 55.58 | 55.58 | 55.58 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 55.58 | 55.58 | 55.58 | 55.58 | 55.58 | 55.58 | 55.58 | 55.58 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Bodies Corporate | % | 8.78 | 8.75 | 8.64 | 8.64 | 8.66 | 8.75 | 9.14 | 8.61 | |
Individuals | % | 30.24 | 30.40 | 30.54 | 30.93 | 30.94 | 30.77 | 30.62 | 31.28 | |
NRIs/OCBs | % | 2.67 | 2.65 | 2.69 | 2.71 | 2.72 | 2.55 | 2.54 | 2.44 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 2.73 | 2.62 | 2.55 | 2.14 | 2.10 | 2.35 | 2.12 | 2.09 | |
Total Non-Institution | % | 44.42 | 44.42 | 44.42 | 44.42 | 44.42 | 44.42 | 44.42 | 44.42 | |
Total Public | % | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | 44.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 42.81 | 42.81 | 42.81 | 42.81 | 42.81 | 42.81 | 42.81 | 42.81 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
Japan's Nikkei 225 led gains in Asia as markets in the region rose across the board, following Wall Street's continued rally for a second straight day.